Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells

M. Fukunaga, N. Makita, L. J. Roberts, J. D. Morrow, K. Takahashi, K. F. Badr

Research output: Contribution to journalArticle

Abstract

The isoprostanes are nonenzymatically generated prostanoids synthesized in vivo in humans and rats through reactions catalyzed by free oxygen radicals. 8-Epi-prostaglandin F(2α) (8-epi-PGF(2α)), an F2-isoprostane, is a potent smooth muscle constrictor. A thromboxane A2 (TxA2) receptor antagonist, SQ 29548, blocks renal vasoconstriction during 8-epi-PGF(2α) administration in rats. With the use of cultured rat aortic smooth muscle cells, we found specific binding sites for [3H]SQ 29548 and for [125I]BOP, a TxA2 agonist. Both ligands were displaced from these binding sites by 8-epi- PGF(2α), although with significantly lesser potency than nonlabeled SQ 29548, I-BOP, or U-46619, a TxA2 agonist. In contrast, 8-epi-PGF(2α) stimulated inositol 1,4,5-trisphosphate production and DNA synthesis in these cells with significantly greater potency than any TxA2 agonist, effects only partially inhibited by SQ 29548. In human TxA2 receptor cDNA-transfected cells, competition by 8-epi-PGF(2α) for specific [3H]SQ 29548 binding was negligible. Thus 8-epi-PGF(2α) probably exerts its biological actions in vascular smooth muscle through activation of receptor sites related to but distinct from TxA2 receptors. The existence of such binding sites suggests novel avenues for investigation into the biology of TxA2 and of free radical-mediated tissue injury.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Cell Physiology
Volume264
Issue number6 33-6
StatePublished - 1993
Externally publishedYes

Fingerprint

Prostaglandins F
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Rats
Cells
Thromboxane A2
Prostaglandin H2 Receptors Thromboxane A2
Binding Sites
Free Radicals
F2-Isoprostanes
Isoprostanes
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Inositol 1,4,5-Trisphosphate
prostaglandin F2alpha receptor
Vasoconstriction
Prostaglandins
Smooth Muscle
Reactive Oxygen Species
Complementary DNA

Keywords

  • isoprostanes
  • phosphoinositide turnover
  • thromboxane A
  • thromboxane receptor

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology
  • Medicine(all)

Cite this

Fukunaga, M., Makita, N., Roberts, L. J., Morrow, J. D., Takahashi, K., & Badr, K. F. (1993). Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. American Journal of Physiology - Cell Physiology, 264(6 33-6).

Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. / Fukunaga, M.; Makita, N.; Roberts, L. J.; Morrow, J. D.; Takahashi, K.; Badr, K. F.

In: American Journal of Physiology - Cell Physiology, Vol. 264, No. 6 33-6, 1993.

Research output: Contribution to journalArticle

Fukunaga, M, Makita, N, Roberts, LJ, Morrow, JD, Takahashi, K & Badr, KF 1993, 'Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells', American Journal of Physiology - Cell Physiology, vol. 264, no. 6 33-6.
Fukunaga, M. ; Makita, N. ; Roberts, L. J. ; Morrow, J. D. ; Takahashi, K. ; Badr, K. F. / Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. In: American Journal of Physiology - Cell Physiology. 1993 ; Vol. 264, No. 6 33-6.
@article{57ade34d9e12493dbe206d72283a89d3,
title = "Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells",
abstract = "The isoprostanes are nonenzymatically generated prostanoids synthesized in vivo in humans and rats through reactions catalyzed by free oxygen radicals. 8-Epi-prostaglandin F(2α) (8-epi-PGF(2α)), an F2-isoprostane, is a potent smooth muscle constrictor. A thromboxane A2 (TxA2) receptor antagonist, SQ 29548, blocks renal vasoconstriction during 8-epi-PGF(2α) administration in rats. With the use of cultured rat aortic smooth muscle cells, we found specific binding sites for [3H]SQ 29548 and for [125I]BOP, a TxA2 agonist. Both ligands were displaced from these binding sites by 8-epi- PGF(2α), although with significantly lesser potency than nonlabeled SQ 29548, I-BOP, or U-46619, a TxA2 agonist. In contrast, 8-epi-PGF(2α) stimulated inositol 1,4,5-trisphosphate production and DNA synthesis in these cells with significantly greater potency than any TxA2 agonist, effects only partially inhibited by SQ 29548. In human TxA2 receptor cDNA-transfected cells, competition by 8-epi-PGF(2α) for specific [3H]SQ 29548 binding was negligible. Thus 8-epi-PGF(2α) probably exerts its biological actions in vascular smooth muscle through activation of receptor sites related to but distinct from TxA2 receptors. The existence of such binding sites suggests novel avenues for investigation into the biology of TxA2 and of free radical-mediated tissue injury.",
keywords = "isoprostanes, phosphoinositide turnover, thromboxane A, thromboxane receptor",
author = "M. Fukunaga and N. Makita and Roberts, {L. J.} and Morrow, {J. D.} and K. Takahashi and Badr, {K. F.}",
year = "1993",
language = "English (US)",
volume = "264",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 33-6",

}

TY - JOUR

T1 - Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells

AU - Fukunaga, M.

AU - Makita, N.

AU - Roberts, L. J.

AU - Morrow, J. D.

AU - Takahashi, K.

AU - Badr, K. F.

PY - 1993

Y1 - 1993

N2 - The isoprostanes are nonenzymatically generated prostanoids synthesized in vivo in humans and rats through reactions catalyzed by free oxygen radicals. 8-Epi-prostaglandin F(2α) (8-epi-PGF(2α)), an F2-isoprostane, is a potent smooth muscle constrictor. A thromboxane A2 (TxA2) receptor antagonist, SQ 29548, blocks renal vasoconstriction during 8-epi-PGF(2α) administration in rats. With the use of cultured rat aortic smooth muscle cells, we found specific binding sites for [3H]SQ 29548 and for [125I]BOP, a TxA2 agonist. Both ligands were displaced from these binding sites by 8-epi- PGF(2α), although with significantly lesser potency than nonlabeled SQ 29548, I-BOP, or U-46619, a TxA2 agonist. In contrast, 8-epi-PGF(2α) stimulated inositol 1,4,5-trisphosphate production and DNA synthesis in these cells with significantly greater potency than any TxA2 agonist, effects only partially inhibited by SQ 29548. In human TxA2 receptor cDNA-transfected cells, competition by 8-epi-PGF(2α) for specific [3H]SQ 29548 binding was negligible. Thus 8-epi-PGF(2α) probably exerts its biological actions in vascular smooth muscle through activation of receptor sites related to but distinct from TxA2 receptors. The existence of such binding sites suggests novel avenues for investigation into the biology of TxA2 and of free radical-mediated tissue injury.

AB - The isoprostanes are nonenzymatically generated prostanoids synthesized in vivo in humans and rats through reactions catalyzed by free oxygen radicals. 8-Epi-prostaglandin F(2α) (8-epi-PGF(2α)), an F2-isoprostane, is a potent smooth muscle constrictor. A thromboxane A2 (TxA2) receptor antagonist, SQ 29548, blocks renal vasoconstriction during 8-epi-PGF(2α) administration in rats. With the use of cultured rat aortic smooth muscle cells, we found specific binding sites for [3H]SQ 29548 and for [125I]BOP, a TxA2 agonist. Both ligands were displaced from these binding sites by 8-epi- PGF(2α), although with significantly lesser potency than nonlabeled SQ 29548, I-BOP, or U-46619, a TxA2 agonist. In contrast, 8-epi-PGF(2α) stimulated inositol 1,4,5-trisphosphate production and DNA synthesis in these cells with significantly greater potency than any TxA2 agonist, effects only partially inhibited by SQ 29548. In human TxA2 receptor cDNA-transfected cells, competition by 8-epi-PGF(2α) for specific [3H]SQ 29548 binding was negligible. Thus 8-epi-PGF(2α) probably exerts its biological actions in vascular smooth muscle through activation of receptor sites related to but distinct from TxA2 receptors. The existence of such binding sites suggests novel avenues for investigation into the biology of TxA2 and of free radical-mediated tissue injury.

KW - isoprostanes

KW - phosphoinositide turnover

KW - thromboxane A

KW - thromboxane receptor

UR - http://www.scopus.com/inward/record.url?scp=0027158234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027158234&partnerID=8YFLogxK

M3 - Article

VL - 264

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 6 33-6

ER -